ATCC now offers a complete suite of male and female CD34+ iPSCs from diverse ethnic groups. iPSCs from African-American, Asian, Caucasian and Hispanic
origin are available for your toxicological experiments, disease modeling studies and pharmacological target validation. These zero-footprint iPSCs are
highly characterized and have been extensively tested to confirm their undifferentiated state. Produce the cells you need using ATCC iPSC research
tools.